Beam reveals what tripped up its base-edited, off-the-shelf CAR-T as it tries to clear FDA hold

[cafead]

via Last month, Beam Therapeutics revealed the FDA intended to place its preclinical off-the-shelf CAR-T therapy on hold. Today, the company revealed the reasons why.

article source